HARP - Harpoon Therapeutics EPS beats by $0.11 beats on revenue March, 10 2021 04:26 PM Harpoon Therapeutics Inc. Harpoon Therapeutics (HARP): Q4 GAAP EPS of -$0.45 beats by $0.11.Revenue of $7.5M (+236.3% Y/Y) beats by $2.32M.Press Release For further details see: Harpoon Therapeutics EPS beats by $0.11, beats on revenue